A Clinical Investigation of the Taperloc® Microplasty™ Hip System
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients requiring relief from painful or disabling joint disease.
Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis
Correction of functional deformity.
Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques.
Revision of previously failed femoral head resurfacing component
Absolute contraindications include:
Relative contraindications include:
uncooperative patient or patient with neurologic disorders who are incapable of following directions,
metabolic disorders which may impair bone formation,
distant foci of infections which may spread to the implant site,
rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram,
vascular insufficiency, muscular atrophy, or neuromuscular disease.